SG11202102116XA - Crystalline forms of 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide - Google Patents
Crystalline forms of 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamideInfo
- Publication number
- SG11202102116XA SG11202102116XA SG11202102116XA SG11202102116XA SG11202102116XA SG 11202102116X A SG11202102116X A SG 11202102116XA SG 11202102116X A SG11202102116X A SG 11202102116XA SG 11202102116X A SG11202102116X A SG 11202102116XA SG 11202102116X A SG11202102116X A SG 11202102116XA
- Authority
- SG
- Singapore
- Prior art keywords
- acryloylpiperidin
- phenoxyphenyl
- nicotinamide
- crystalline forms
- crystalline
- Prior art date
Links
- MZPVEMOYADUARK-UHFFFAOYSA-N 2-(4-phenoxyphenyl)-6-(1-prop-2-enoylpiperidin-4-yl)pyridine-3-carboxamide Chemical compound NC(=O)C1=CC=C(C2CCN(CC2)C(=O)C=C)N=C1C(C=C1)=CC=C1OC1=CC=CC=C1 MZPVEMOYADUARK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862732994P | 2018-09-18 | 2018-09-18 | |
| PCT/CN2019/106433 WO2020057549A1 (fr) | 2018-09-18 | 2019-09-18 | Formes cristallines de 6- (1-acryloylpipéridin-4-yl)-2-(4-phénoxyphényl) nicotinamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202102116XA true SG11202102116XA (en) | 2021-04-29 |
Family
ID=69888278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202102116XA SG11202102116XA (en) | 2018-09-18 | 2019-09-18 | Crystalline forms of 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11945792B2 (fr) |
| EP (1) | EP3853217B1 (fr) |
| JP (1) | JP2022501351A (fr) |
| KR (1) | KR20210060501A (fr) |
| CN (2) | CN112654607B (fr) |
| AU (1) | AU2019341284B2 (fr) |
| CA (1) | CA3111114A1 (fr) |
| ES (1) | ES2951420T3 (fr) |
| MX (1) | MX2021003064A (fr) |
| SG (1) | SG11202102116XA (fr) |
| WO (1) | WO2020057549A1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015028662A1 (fr) | 2013-08-30 | 2015-03-05 | Consejo Superior De Investigaciones Cientificas (Csic) | Compositions et méthodes de caractérisation et de traitement de la polyarthrite rhumatoïde |
| KR102272792B1 (ko) * | 2013-09-30 | 2021-07-05 | 광저우 이노케어 파마 테크 씨오., 엘티디. | Ｂｔｋ의 치환된 니코틴이미드 저해제 및 그의 제조 방법 및 암, 염증 및 자가면역 질환에의 용도 |
| WO2016100914A1 (fr) * | 2014-12-18 | 2016-06-23 | Gourlay Steven | Traitement du pemphigus |
| PL3236943T3 (pl) * | 2014-12-24 | 2023-05-29 | Principia Biopharma Inc. | Kompozycje do krętniczo-czczego dostarczania leków |
-
2019
- 2019-09-18 SG SG11202102116XA patent/SG11202102116XA/en unknown
- 2019-09-18 ES ES19862150T patent/ES2951420T3/es active Active
- 2019-09-18 CN CN201980058360.8A patent/CN112654607B/zh active Active
- 2019-09-18 EP EP19862150.0A patent/EP3853217B1/fr active Active
- 2019-09-18 AU AU2019341284A patent/AU2019341284B2/en active Active
- 2019-09-18 JP JP2021515106A patent/JP2022501351A/ja active Pending
- 2019-09-18 CA CA3111114A patent/CA3111114A1/fr active Pending
- 2019-09-18 MX MX2021003064A patent/MX2021003064A/es unknown
- 2019-09-18 CN CN202211635896.1A patent/CN116496247A/zh active Pending
- 2019-09-18 WO PCT/CN2019/106433 patent/WO2020057549A1/fr unknown
- 2019-09-18 KR KR1020217009903A patent/KR20210060501A/ko unknown
-
2021
- 2021-03-03 US US17/191,310 patent/US11945792B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN112654607A (zh) | 2021-04-13 |
| KR20210060501A (ko) | 2021-05-26 |
| WO2020057549A1 (fr) | 2020-03-26 |
| EP3853217A4 (fr) | 2022-05-04 |
| EP3853217B1 (fr) | 2023-06-07 |
| ES2951420T3 (es) | 2023-10-20 |
| CA3111114A1 (fr) | 2020-03-26 |
| AU2019341284A1 (en) | 2021-04-15 |
| US20210188801A1 (en) | 2021-06-24 |
| CN112654607B (zh) | 2023-01-13 |
| EP3853217A1 (fr) | 2021-07-28 |
| MX2021003064A (es) | 2021-05-27 |
| AU2019341284B2 (en) | 2024-09-05 |
| US11945792B2 (en) | 2024-04-02 |
| CN116496247A (zh) | 2023-07-28 |
| JP2022501351A (ja) | 2022-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1247726A1 (zh) | 烟酰胺核苷的結晶形式 | |
| EP3174891A4 (fr) | Forme cristalline du riboside de nicotinamide | |
| HK1246667A1 (zh) | 作為jak抑制劑的2-(吡唑並吡啶-3-基)嘧啶衍生物 | |
| PL3577125T3 (pl) | Postacie krystaliczne alafenamidu tenofowiru | |
| SI3380554T1 (sl) | Kristalne oblike per-kloro-gama-ciklodekstrinov | |
| EP3390422A4 (fr) | Formes cristallines de lnt | |
| PL3613733T3 (pl) | Nowy krystaliczny stały chlorowodorek 3-fenylo-4-propylo-1-(pirydyn-2-ylo)-1H-pirazol-5-olu | |
| HK1244274A1 (zh) | C21h22ci2n4o2的晶型 | |
| IL260004A (en) | Crystalline forms of quinolone analogs and their salts | |
| SI3529236T1 (sl) | Kristalinične oblike eravaciklina | |
| EP3377887A4 (fr) | Procédé d'échange compétitif contrôlé | |
| PL3532457T3 (pl) | Postacie krystaliczne hydroksynorketaminy | |
| HK1247192A1 (zh) | 吡啶或嘧啶衍生物 | |
| IL269792B (en) | Crystalline forms of (s)–apoxolner | |
| IL253479A0 (en) | Crystalline forms of efinconazole | |
| IL269073A (en) | Crystalline forms of obeticholic acid | |
| HUE057841T2 (hu) | A jelérzékelési mód adaptív kiválasztása | |
| IL270961A (en) | Crystalline form of N-butyldeoxygalactonogirimycin | |
| HK1249518A1 (zh) | 取代吡啶並嘧啶類化合物的合成工藝 | |
| LT3630729T (lt) | Pirimidino junginys | |
| IL288950A (en) | History of pyridine-3-yl | |
| SG11202103861YA (en) | Amorphous solid dispersion comprising 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide | |
| SG11202102116XA (en) | Crystalline forms of 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide | |
| IL274758A (en) | Crystalline forms of praquinostat | |
| SG11202109213RA (en) | Process for preparing 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide |